<code id='CA06461A94'></code><style id='CA06461A94'></style>
    • <acronym id='CA06461A94'></acronym>
      <center id='CA06461A94'><center id='CA06461A94'><tfoot id='CA06461A94'></tfoot></center><abbr id='CA06461A94'><dir id='CA06461A94'><tfoot id='CA06461A94'></tfoot><noframes id='CA06461A94'>

    • <optgroup id='CA06461A94'><strike id='CA06461A94'><sup id='CA06461A94'></sup></strike><code id='CA06461A94'></code></optgroup>
        1. <b id='CA06461A94'><label id='CA06461A94'><select id='CA06461A94'><dt id='CA06461A94'><span id='CA06461A94'></span></dt></select></label></b><u id='CA06461A94'></u>
          <i id='CA06461A94'><strike id='CA06461A94'><tt id='CA06461A94'><pre id='CA06461A94'></pre></tt></strike></i>

          entertainment

          entertainment

          author:leisure time    Page View:376
          Mayo Clinic, in Rochester, Minnesota on
          Photo by KEREM YUCEL/AFP via Getty Images

          SAN FRANCISCO — Mayo Clinic has signed Silicon Valley tech startup Cerebras as its first generative AI partner, the health system announced Monday.

          The health system — known for its cutting-edge research and willingness to partner with tech companies — will give Cerebras millions of dollars to help build technology tools based on Mayo’s trove of de-identified patient data, leaders announced at the J.P. Morgan Healthcare Conference. Mayo and Cerebras did not disclose the dollar amount, but Cerebras said it was a multimillion, multi-year contract.

          advertisement

          With roughly 380 employees, Cerebras builds and sells supercomputers specifically designed for AI applications across several industries — pitting the upstart in direct competition with the market leader Nvidia Corp. Life sciences giants including GSK have used its technology for drug discovery, and it has partnered with a health network in United Arab Emirates, but this is Cerebras’ first AI contract with a U.S. health system. The deal gives Mayo access to Cerebras’ supercomputers as well as a Cerebras team to help develop health-tuned models; Mayo will then own whatever they build.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more
          As AI regulations shape up, health tech startups beg for clarity
          As AI regulations shape up, health tech startups beg for clarity

          AdobeThefederalgovernment’splantoboostitsoversightoftheuseofartificialintelligencetoolsinhealthcared

          read more
          Heart attack and stroke risk calculators need revising
          Heart attack and stroke risk calculators need revising

          AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

          read more

          CDC advisers recommend seasonal use of Pfizer RSV shot

          AvialofPfizer’snewvaccinetoprotectinfantsagainstrespiratorysyncytialvirus.CourtesyPfizerPfizer’snews